DHT.UN vs. TLRY, CRON, THCX, GUD, WEED, CPH, ACB, SUGR, OGI, and FIRE
Should you be buying DRI Healthcare Trust stock or one of its competitors? The main competitors of DRI Healthcare Trust include Tilray Brands (TLRY), Cronos Group (CRON), Hydropothecary (THCX), Knight Therapeutics (GUD), Canopy Growth (WEED), Cipher Pharmaceuticals (CPH), Aurora Cannabis (ACB), SugarBud Craft Growers (SUGR), Organigram (OGI), and Supreme Cannabis (FIRE). These companies are all part of the "drug manufacturers - specialty & generic" industry.
DRI Healthcare Trust vs. Its Competitors
DRI Healthcare Trust (TSE:DHT.UN) and Tilray Brands (TSE:TLRY) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, risk, media sentiment, valuation, dividends, profitability, analyst recommendations and institutional ownership.
DRI Healthcare Trust has a net margin of 5.02% compared to Tilray Brands' net margin of -30.02%. DRI Healthcare Trust's return on equity of 2.06% beat Tilray Brands' return on equity.
DRI Healthcare Trust has a beta of 0.28437, meaning that its stock price is 72% less volatile than the S&P 500. Comparatively, Tilray Brands has a beta of 3.71147, meaning that its stock price is 271% more volatile than the S&P 500.
1.0% of DRI Healthcare Trust shares are owned by institutional investors. Comparatively, 4.7% of Tilray Brands shares are owned by institutional investors. 0.1% of DRI Healthcare Trust shares are owned by company insiders. Comparatively, 0.7% of Tilray Brands shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
In the previous week, Tilray Brands had 2 more articles in the media than DRI Healthcare Trust. MarketBeat recorded 2 mentions for Tilray Brands and 0 mentions for DRI Healthcare Trust. Tilray Brands' average media sentiment score of 0.72 beat DRI Healthcare Trust's score of 0.00 indicating that Tilray Brands is being referred to more favorably in the news media.
DRI Healthcare Trust has higher earnings, but lower revenue than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than DRI Healthcare Trust, indicating that it is currently the more affordable of the two stocks.
DRI Healthcare Trust currently has a consensus price target of C$19.50, indicating a potential upside of 33.84%. Given DRI Healthcare Trust's stronger consensus rating and higher probable upside, analysts clearly believe DRI Healthcare Trust is more favorable than Tilray Brands.
Summary
DRI Healthcare Trust beats Tilray Brands on 10 of the 16 factors compared between the two stocks.
Get DRI Healthcare Trust News Delivered to You Automatically
Sign up to receive the latest news and ratings for DHT.UN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding DHT.UN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
DHT.UN vs. The Competition
DRI Healthcare Trust Competitors List
Related Companies and Tools
This page (TSE:DHT.UN) was last updated on 9/13/2025 by MarketBeat.com Staff
Free DHT.UN Stock Alerts